Ignite Creation Date:
2025-12-24 @ 7:15 PM
Ignite Modification Date:
2026-01-04 @ 12:25 AM
Study NCT ID:
NCT02826603
Status:
COMPLETED
Last Update Posted:
2019-07-09
First Post:
2015-11-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06-22
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-07-09
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-30
First Submit QC Date:
None
Study First Post Date:
2016-07-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-06-17
Results First Submit QC Date:
None
Results First Post Date:
2019-07-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-06-18
Last Update Post Date:
2019-07-09
Last Update Post Date Type:
ACTUAL